EWOS STEPS UP EFFORTS IN FISH HEALTH RESEARCH
EWOS invests USD 9.5 million in a new research centre named EWOS Fish Health Centre. The centre will be located in the Los Lagos region of Chile. Construction begins today.
“Food is important for health – this is the case for fish as well. Feed is a key part of the solution to improving fish health. Through research and innovation, we will offer our customers the best health feed products that can possibly be made,” commented EWOS CEO Einar Wathne.
The Board of EWOS Group has decided to invest over 80 million kroner in a new EWOS Fish Health Centre. The unit will be located in the Los Lagos region of Chile. Building permits and other necessary licenses are in place, and EWOS will start construction today February 23rd.
Record investment and continuing tradition
Health feeds are a priority for EWOS, particularly health feed for farmed salmon. Through our product development, we have contributed to a reduced dependence on medicines and environmentally controversial drugs in salmon farming. EWOS Innovation in Dirdal has through decades built up leading competency on research and innovation in this area. The units in Norway and Chile will cooperate and complement each other in the future.
CEO Einar Wathne commented:
“Through decades, EWOS has made bold investments in research and development. In 1996, we spent 20 million kroner to build the feed technology centre in Dirdal. Now we bring this tradition further. The investment we are now making, is as far as we know the largest investment in research and development made by a private operator in the salmon industry. A record investment of which we are proud, and an investment that will benefit both our company and the aquaculture industry in general.”
Adel El-Mowafi, Research Director at EWOS Innovation, expects that the unit in Chile will increase research capacity significantly:
“We will be able to do four to five times more studies each year and speed up our investigation into how feed can reduce the harmful effects of sea lice. We expect to quickly make new improvements on existing products and within two to three years we plan to launch new health feed products. Simultaneously, the new capacity will enable us to react even quicker to novel health challenges that may emerge in the future.”
EWOS Fish Health Centre will extend over 2950 square meters and contain systems for water purification, hatchery, research area and laboratories. From start-up, the centre will have 25-30 employees.
The researchers will focus on developing feed products that can help to combat challenges from sea lice, as well as the diseases like SRS and AGD.
“Threats such as sea lice and diseases are the most serious challenges to salmon farming. These threats limit opportunities for sustainable growth of the industry and also affect both reputation and financial results. Feed cannot solve this challenge alone. However, our results have shown that we can make an important contribution in partnership with other measures in the aquaculture industry. Through this record investment, we increase our contribution significantly,” commented Einar Wathne.
About EWOS Group:
Holds approximately 1/3 of the world market for feed for farmed salmon and trout
Sold over 1.1 million tonnes of feed in 2013, with revenues of more than NOK 10,8 billion
1,039 employees (2013)
Extensive research and development in fish nutrition and feed technology through EWOS Innovation in Norway and Chile
22 production lines in seven factories – three in Norway, as well as one in Chile, Canada, Scotland and Vietnam
Owned by Altor Equity Partners and Bain Capital
For further information, please contact:
Communications Manager Hanne Dankertsen
+47 994 49 173